Dutton & Associates Announces Investment Opinion: Arcadia Resources Inc. Strong Buy Rating in Update by Dutton Associates.EL DORADO El Dorado, legendary country of South America El Dorado (ĕl`dərä`dō, –rā`–) [Span.,=the gilded man], legendary country of the Golden Man sought by adventurers in South America. HILLS, Calif. -- Dutton Associates updates coverage of Arcadia Resources Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : ACDI ACDI Agence Canadienne de Développement International (Canadian International Development Agency) ACDI Agricultural Cooperative Development International ACDI Asynchronous Communications Device Interface (IBM) ), reiterating a Strong Buy rating and our 12-month price of $2.75. The 10-page report by Dutton senior analyst David Riedel is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Reuters, and other leading financial portals Financial Portal A website that provides a variety of financial data and information, acting as an information hub for clients who are individual investors requiring timely financial news and data to make their investment decisions. . Arcadia Resources, Inc. has combined a range of businesses that make it an excellent play on the aging of the U.S. population and increased spending on healthcare. The Company is a significant player in two very attractive sections of the healthcare business: healthcare staffing (including homecare) and durable medical equipment Durable medical equipment is a term of art used to describe certain Medicare benefits, that is, whether Medicare may pay for the item. The item is defined by Title XVIII the Social Security Act: DME - Distributed Management Environment ). A growing pharmacy business rounds out the offering. About Dutton Associates Dutton Associates is one of the largest independent investment research firms in the U.S. Its 27 senior analysts are primarily CFAs, and have expertise in many industries. Dutton Associates provides continuing analyst coverage of over 90 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors. The cost of enrollment in our one-year continuing research program is US $33,000 prepaid before commencement of our research activities. We received $33,000 from the Company for 4 quarterly Research Reports with coverage commencing on 10/18/04. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion